VIM and breast cancer: Overexpressed in several aggressive breast cancer cell lines where HRD1 was verified to be significantly downregulated (Fig. 1a, b), Vimentin plays a pivotal role at the very center of the EMT process through which the increased cellular invasion and migration lead to the metastasis of breast cancer [9, 24].